CHEST:肺炎带来的负担现状——纽约市近五年的调查研究

2017-05-02 MedSci MedSci原创

虽然在纽约市(NYC)肺炎是导致死亡的主要原因,但有关纽约市肺炎现状的数据仍然有限。比非社区环境中获得的肺炎相比,在社区环境中获得的肺炎,更容易被疫苗预防,且更易被一线抗生素治疗。近期,一项发表在杂志CHEST上的研究旨在评估在2010-2014年期间,与社区获得-(CAP-),医疗保健相关-(HCAP-),医院获得-(HAP-)和呼吸机相关-(VAP-)肺炎的住院负担。研究者们对纽约市18岁及以

虽然在纽约市(NYC)肺炎是导致死亡的主要原因,但有关纽约市肺炎现状的数据仍然有限。比非社区环境中获得的肺炎相比,在社区环境中获得的肺炎,更容易被疫苗预防,且更易被一线抗生素治疗。


近期,一项发表在杂志CHEST上的研究旨在评估在2010-2014年期间,与社区获得-(CAP-),医疗保健相关-(HCAP-),医院获得-(HAP-)和呼吸机相关-(VAP-)肺炎的住院负担。

研究者们对纽约市18岁及以上居民的医院出院报告进行了回顾性分析。肺炎相关住院定义为,包括诊断编码中任何诊断为肺炎的住院治疗。使用公布的临床指南,研究者们将住院患者分为CAP、HCAP、HAP和VAP的类别,并将社区获得肺炎定义为CAP和HCAP的组合。

此项研究共评估了4614108例住院患者,其中283,927例(6.2%)涉及肺炎。肺炎相关住院治疗中,154,158例(54.3%)为CAP,85,656例(30.2%)为HCAP,39,712例(14.0%)为HAP,4,401例(1.6%)为VAP。住院期间死亡的发生在CAP相关住院治疗中为7.9%,而HCAP相关为15.7%,HAP相关为20.7%,VAP相关为21.6%。

此项研究表明:纽约市大多数与肺炎有关的住院治疗涉及在社区环境中获得的肺炎。只有15.6%的肺炎相关住院治疗被归类为HAP或VAP,但这些肺炎占肺炎相关住院的死亡大于25%。

原始出处:
Corrado RE, Lee D, et al. Burden of Adult Community-Acquired, Healthcare-Associated, Hospital-Acquired, and Ventilator-Associated Pneumonia - New York City, 2010-2014. Chest. 2017 Apr 25. pii: S0012-3692(17)30779-1. doi: 10.1016/j.chest.2017.04.162.
 
本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2050668, encodeId=801120506682f, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 13 05:00:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929326, encodeId=06cc192932622, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Feb 19 22:00:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193208, encodeId=292c19320831, content=学习了谢谢谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Wed May 03 08:51:03 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193090, encodeId=70a9193090f3, content=社区获得性肺炎在门诊治疗就可以了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed May 03 05:52:48 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192981, encodeId=26ff192981bf, content=学习了增加知识了!:, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue May 02 21:03:42 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192909, encodeId=a3851929090e, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/9bf448cdab79d4469a2334f81edf7549.jpg, createdBy=52952053313, createdName=sjmrwan, createdTime=Tue May 02 13:05:32 CST 2017, time=2017-05-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2050668, encodeId=801120506682f, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 13 05:00:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929326, encodeId=06cc192932622, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Feb 19 22:00:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193208, encodeId=292c19320831, content=学习了谢谢谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Wed May 03 08:51:03 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193090, encodeId=70a9193090f3, content=社区获得性肺炎在门诊治疗就可以了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed May 03 05:52:48 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192981, encodeId=26ff192981bf, content=学习了增加知识了!:, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue May 02 21:03:42 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192909, encodeId=a3851929090e, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/9bf448cdab79d4469a2334f81edf7549.jpg, createdBy=52952053313, createdName=sjmrwan, createdTime=Tue May 02 13:05:32 CST 2017, time=2017-05-02, status=1, ipAttribution=)]
    2018-02-19 Smile2680
  3. [GetPortalCommentsPageByObjectIdResponse(id=2050668, encodeId=801120506682f, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 13 05:00:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929326, encodeId=06cc192932622, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Feb 19 22:00:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193208, encodeId=292c19320831, content=学习了谢谢谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Wed May 03 08:51:03 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193090, encodeId=70a9193090f3, content=社区获得性肺炎在门诊治疗就可以了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed May 03 05:52:48 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192981, encodeId=26ff192981bf, content=学习了增加知识了!:, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue May 02 21:03:42 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192909, encodeId=a3851929090e, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/9bf448cdab79d4469a2334f81edf7549.jpg, createdBy=52952053313, createdName=sjmrwan, createdTime=Tue May 02 13:05:32 CST 2017, time=2017-05-02, status=1, ipAttribution=)]
    2017-05-03 tanxingdoctor

    学习了谢谢谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2050668, encodeId=801120506682f, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 13 05:00:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929326, encodeId=06cc192932622, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Feb 19 22:00:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193208, encodeId=292c19320831, content=学习了谢谢谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Wed May 03 08:51:03 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193090, encodeId=70a9193090f3, content=社区获得性肺炎在门诊治疗就可以了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed May 03 05:52:48 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192981, encodeId=26ff192981bf, content=学习了增加知识了!:, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue May 02 21:03:42 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192909, encodeId=a3851929090e, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/9bf448cdab79d4469a2334f81edf7549.jpg, createdBy=52952053313, createdName=sjmrwan, createdTime=Tue May 02 13:05:32 CST 2017, time=2017-05-02, status=1, ipAttribution=)]
    2017-05-03 有备才能无患

    社区获得性肺炎在门诊治疗就可以了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2050668, encodeId=801120506682f, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 13 05:00:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929326, encodeId=06cc192932622, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Feb 19 22:00:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193208, encodeId=292c19320831, content=学习了谢谢谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Wed May 03 08:51:03 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193090, encodeId=70a9193090f3, content=社区获得性肺炎在门诊治疗就可以了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed May 03 05:52:48 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192981, encodeId=26ff192981bf, content=学习了增加知识了!:, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue May 02 21:03:42 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192909, encodeId=a3851929090e, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/9bf448cdab79d4469a2334f81edf7549.jpg, createdBy=52952053313, createdName=sjmrwan, createdTime=Tue May 02 13:05:32 CST 2017, time=2017-05-02, status=1, ipAttribution=)]
    2017-05-02 大爰

    学习了增加知识了!:

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2050668, encodeId=801120506682f, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Jul 13 05:00:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929326, encodeId=06cc192932622, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Mon Feb 19 22:00:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193208, encodeId=292c19320831, content=学习了谢谢谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Wed May 03 08:51:03 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=193090, encodeId=70a9193090f3, content=社区获得性肺炎在门诊治疗就可以了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed May 03 05:52:48 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192981, encodeId=26ff192981bf, content=学习了增加知识了!:, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Tue May 02 21:03:42 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192909, encodeId=a3851929090e, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/02/9bf448cdab79d4469a2334f81edf7549.jpg, createdBy=52952053313, createdName=sjmrwan, createdTime=Tue May 02 13:05:32 CST 2017, time=2017-05-02, status=1, ipAttribution=)]
    2017-05-02 sjmrwan

    学习了!

    0

相关资讯

BMJ:社区获得性肺炎与心衰的相关性 不可不知

社区获得性肺炎是与高发病率和死亡率相关的常见疾病,不考虑年龄。此病是美国第七大主要死因。2017年2月,发表在《BMJ》的一项由加拿大科学家进行的10年随访的前瞻性对照研究考察了社会获得性肺炎后心衰风险。请看本期多学科讨论组临床药师各抒己见为您梳理本文看点——目的:旨在确定社区获得性肺炎对各年龄层的受影响患者和各感染严重程度患者的心衰发生率的归因风险。设计:队列研究。地点:加拿大2000~2002

Br J Clin Pharmacol:震惊!吸入类固醇可增加哮喘患者肺炎的发生风险

既往研究表明吸入糖皮质激素(ICS)可增加COPD患者肺炎的发生风险,但是是否会增加哮喘患者肺炎的发生风险目前尚未清楚。,本研究旨在探究ICS是否会增加12-35岁哮喘患者肺炎的发生风险。研究人员使用1990-2007年魁北克健康保险数据库的资料共纳入了152412名研究对象。结果随访期间1928名参与者发生肺炎。分析数据发现当前ICS的使用与肺炎的发生风险相关(RR 1.83;95% CI 1.

CMAJ:警示!苯二氮䓬类药物或增加阿尔兹海默病患者肺炎风险

2017年4月,发表在《CMAJ》的一项研究表明,苯二氮?类药物的使用与阿尔兹海默病患者肺炎风险的增加相关。当权衡该群体苯二氮卓类药物的风险和获益时,应予以考虑肺炎的风险。背景:苯二氮卓类药物和相似作用的非苯二氮卓类药物(Z药物)是否与老年人肺炎风险的增加相关是未知的。研究人员在社区管理的阿尔兹海默病成年患者中调查了该相关性,这些患者常使用镇静/催眠类药物,并且易发肺炎。方法:芬兰药物使用和阿尔兹

J ANTIMICROB CHEMOTH:MRSA肺炎 甲氧苄氨嘧啶/磺胺甲恶唑pk万古霉素

肺炎是住院患者和长期护理设备使用患者发病和死亡的重要原因。2016年12月,发表在《J Antimicrob Chemother》的一项由以色列科学家进行的病例对照研究,比较了甲氧苄氨嘧啶/磺胺甲恶唑和万古霉素治疗医疗/呼吸机相关MRSA肺炎的有效性和安全性。请看本期多学科讨论组临床药师各抒己见为您梳理本文看点——目的:现有的MRSA肺炎的治疗选择有限。甲氧苄氨嘧啶/磺胺甲恶唑由于其杀菌的抗MRS

J Am Med Dir Assoc:老年患者误吸相关肺炎的诊断及研究进展

在临床上,口咽吞咽困难(OD)在老年患者中并不少见。而吞咽困难往往是导致老年患者误吸、窒息、肺部感染的高危因素。最近J Am Med Dir Assoc一篇文章针对老年患者的吞咽困难现状及诊断和管理进行了报道。该文章指出,OD的现象普遍存在与老年患者中,影响着27%-91%的70岁以上的老年人的生活。尽管OD能够通过临床手段被很好的诊断,但是在临床工作中医师一般很少针对患者进行系统的筛查,在老年社

Plos One:降钙素原对社区获得性肺炎的门诊患者选择抗生素方案的意义

近期,一项发表在杂志Plos One上的研究旨在评估降钙素原(PCT)在指导低风险社区获得性肺炎(CAP)患者中初次选择抗生素方案中的作用。此项研究包括CAP和肺炎严重性指数风险级别为I-II的门诊患者。抗菌素选择是基于使用快速测量的PCT水平的结果。根据血清PCT水平,患者被分配到两种治疗策略:如果PCT <0.5ng / ml,则口服阿奇霉素;如果PCT≥0.5ng/ ml则使用左氧氟沙